92 related articles for article (PubMed ID: 23403918)
21. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
[TBL] [Abstract][Full Text] [Related]
22. Characterization of an amino-terminal fragment of insulin-like growth factor binding protein-3 and its effects in MCF-7 breast cancer cells.
Salahifar H; Firth SM; Baxter RC; Martin JL
Growth Horm IGF Res; 2000 Dec; 10(6):367-77. PubMed ID: 11161968
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and spectroscopic studies of human melanotransferrin (MTf): electron-paramagnetic resonance evidence for a difference between the iron-binding site of MTf and other transferrins.
Farnaud S; Amini M; Rapisarda C; Cammack R; Bui T; Drake A; Evans RW; Suryo Rahmanto Y; Richardson DR
Int J Biochem Cell Biol; 2008; 40(12):2739-45. PubMed ID: 18691669
[TBL] [Abstract][Full Text] [Related]
24. Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis.
Beattie J; Phillips K; Shand JH; Szymanowska M; Flint DJ; Allan GJ
J Mol Endocrinol; 2005 Feb; 34(1):163-75. PubMed ID: 15691886
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-independent effects mediated by a C-terminal metal-binding domain of insulin-like growth factor binding protein-3.
Singh B; Charkowicz D; Mascarenhas D
J Biol Chem; 2004 Jan; 279(1):477-87. PubMed ID: 14576163
[TBL] [Abstract][Full Text] [Related]
26. Terbium chelation, a specific fluorescent tagging of human transferrin. Optimization of conditions in view of its application to the HPLC analysis of carbohydrate-deficient transferrin (CDT).
Nicotra S; Sorio D; Filippi G; De Gioia L; Paterlini V; De Palo EF; Grandori R; Tagliaro F; Santambrogio C
Anal Bioanal Chem; 2017 Nov; 409(28):6605-6612. PubMed ID: 28971232
[TBL] [Abstract][Full Text] [Related]
27. Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization.
Lee KW; Liu B; Ma L; Li H; Bang P; Koeffler HP; Cohen P
J Biol Chem; 2004 Jan; 279(1):469-76. PubMed ID: 14576164
[TBL] [Abstract][Full Text] [Related]
28. The binding and transport of alternative metals by transferrin.
Vincent JB; Love S
Biochim Biophys Acta; 2012 Mar; 1820(3):362-78. PubMed ID: 21782896
[TBL] [Abstract][Full Text] [Related]
29. Competitive binding of Fe3+, Cr3+, and Ni2+ to transferrin.
Quarles CD; Marcus RK; Brumaghim JL
J Biol Inorg Chem; 2011 Aug; 16(6):913-21. PubMed ID: 21678080
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Nonferrous Metals as Potential In Vivo Tracers of Transferrin-Based Therapeutics.
Zhao H; Wang S; Nguyen SN; Elci SG; Kaltashov IA
J Am Soc Mass Spectrom; 2016 Feb; 27(2):211-9. PubMed ID: 26392277
[TBL] [Abstract][Full Text] [Related]
31. Unfolding of iron and copper complexes of human lactoferrin and transferrin.
Harrington JP; Stuart J; Jones A
Int J Biochem; 1987; 19(10):1001-8. PubMed ID: 3666279
[TBL] [Abstract][Full Text] [Related]
32. Comparative binding study of aluminum and chromium to human transferrin. Effect of iron.
Moshtaghie AA; Ani M; Bazrafshan MR
Biol Trace Elem Res; 1992; 32():39-46. PubMed ID: 1375080
[TBL] [Abstract][Full Text] [Related]
33. Posttranslational modifications of the insulin-like growth factor-binding protein 3 in patients with type 2 diabetes mellitus assessed by affinity chromatography.
Nedić O; Lagundžin D; Masnikosa R
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 904():93-8. PubMed ID: 22884472
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Transferrin in the Urine of Patients with Bladder Cancer Using Nanobodies.
Sachko AM; Goryainova OS; Ivanova TI; Nikolaeva IY; Tarnopolskaia ME; Bychkov AY; Gaas MY; Vorob'ev NV; Kaprin AD; Shegay PV; Tillib SV
Biochemistry (Mosc); 2023 Aug; 88(8):1105-1115. PubMed ID: 37758310
[TBL] [Abstract][Full Text] [Related]
35. Measurement of interaction behavior of six biologically important noble metal ions with the iron(III) binding protein, apo-transferrin, using mobility-shift affinity electrophoresis.
Alhazmi HA
Pharmazie; 2018 Mar; 73(3):143-149. PubMed ID: 29544561
[TBL] [Abstract][Full Text] [Related]
36. Indispensability of Iron for the Growth of Cultured Chick Cells: (iron/transition metal/transferrin/chick embryonic cell/myogenesis).
Saito K; Hagiwara Y; Hasegawa T; Ozawa E
Dev Growth Differ; 1982; 24(6):571-580. PubMed ID: 37281840
[TBL] [Abstract][Full Text] [Related]
37. Potential clinical applications of chelating drugs in diseases targeting transferrin-bound iron and other metals.
Kontoghiorghe CN; Kolnagou A; Kontoghiorghes GJ
Expert Opin Investig Drugs; 2013 May; 22(5):591-618. PubMed ID: 23586878
[TBL] [Abstract][Full Text] [Related]
38. Receptor recognition of transferrin bound to lanthanides and actinides: a discriminating step in cellular acquisition of f-block metals.
Deblonde GJ; Sturzbecher-Hoehne M; Mason AB; Abergel RJ
Metallomics; 2013 Jun; 5(6):619-26. PubMed ID: 23446908
[TBL] [Abstract][Full Text] [Related]
39. The acid-labile subunit of the serum insulin-like growth factor-binding protein complexes. Structural determination by molecular modeling and electron microscopy.
Janosi JB; Ramsland PA; Mott MR; Firth SM; Baxter RC; Delhanty PJ
J Biol Chem; 1999 Aug; 274(33):23328-32. PubMed ID: 10438509
[TBL] [Abstract][Full Text] [Related]
40. The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotective agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] and its hydrolysis product ADR-925.
Hasinoff BB; Kala SV
Agents Actions; 1993 May; 39(1-2):72-81. PubMed ID: 8285144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
